Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Melissa L. Humphrey"'
Autor:
Megan R. Fleming, S. Christian Cheatham, Melissa L. Humphrey, Katherine M. Shea, Michael B. Kays, Eun Kyoung Chung, Daniel P. Healy
Publikováno v:
The Journal of Clinical Pharmacology. 54:324-330
The study objective was to evaluate meropenem pharmacokinetics and pharmacodynamics in morbid obesity. Nine patients hospitalized in an intensive care unit with a body mass index ≥40 kg/m(2) received meropenem 500 mg or 1 g q6h, infused over 0.5 ho
Publikováno v:
Journal of Pharmacy Technology. 28:243-248
Objective:To examine the literature surrounding the effects of omeprazole on oral iron absorption and discuss the long-term use of omeprazole and its effect on vitamins C and B12, calcium, and magnesium absorption.Data Sources:The PubMed and MEDLINE
Autor:
Michael B. Kays, David W. Smith, Megan R. Fleming, Matthew F. Wack, S. Christian Cheatham, Kevin M. Sowinski, Melissa L. Humphrey, Katherine M. Shea, Daniel P. Healy
Publikováno v:
International Journal of Antimicrobial Agents. 37:46-50
The objective of this study was to evaluate the steady-state pharmacokinetics and pharmacodynamics of cefepime administered by prolonged infusion in hospitalised patients requiring antimicrobial therapy. Nine patients received 1g every 8h (q8h), infu
Autor:
S Christian, Cheatham, Megan R, Fleming, Daniel P, Healy, Eun Kyoung, Chung, Katherine M, Shea, Melissa L, Humphrey, Michael B, Kays
Publikováno v:
Journal of clinical pharmacology. 54(3)
The study objective was to evaluate meropenem pharmacokinetics and pharmacodynamics in morbid obesity. Nine patients hospitalized in an intensive care unit with a body mass index ≥40 kg/m(2) received meropenem 500 mg or 1 g q6h, infused over 0.5 ho
Autor:
S. Christian Cheatham, Megan R. Fleming, Daniel P. Healy, Christina E.K. Chung, Michael B. Kays, Melissa L. Humphrey, Katherine M. Shea
Publikováno v:
International journal of antimicrobial agents. 41(1)
The study objective was to evaluate steady-state pharmacokinetics and pharmacodynamics of piperacillin and tazobactam administered by prolonged infusion in obese patients. Fourteen hospitalised patients weighing >120 kg received piperacillin/tazobact